Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients

Syed Quadery (Sheffield, United Kingdom), Syed Quadery, Catherine Billings, Jim Wild, Andy Swift, Smitha Rajaram, Christine Davies, Catherine Hill, Steven Thomas, Peter Braidley, Steven Hunter, Iain Armstrong, Neil Hamilton, Allan Lawrie, Judith Hurdman, Athanasios Charalampopoulos, Ian Sabroe, Robin Condliffe, Charlie Elliot, David Kiely

Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session: Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Session type: Poster Discussion
Number: 3605
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Syed Quadery (Sheffield, United Kingdom), Syed Quadery, Catherine Billings, Jim Wild, Andy Swift, Smitha Rajaram, Christine Davies, Catherine Hill, Steven Thomas, Peter Braidley, Steven Hunter, Iain Armstrong, Neil Hamilton, Allan Lawrie, Judith Hurdman, Athanasios Charalampopoulos, Ian Sabroe, Robin Condliffe, Charlie Elliot, David Kiely. Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients. Eur Respir J 2016; 48: Suppl. 60, 3605

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir J, 50 (4) 1700465; 10.1183/13993003.00465-2017
Year: 2017



Chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension
Year: 2015




Chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017


Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018
Year: 2019



Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160108
Year: 2017



Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2017; 26: 160111
Year: 2017



Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with distal lesions
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 364s
Year: 2006

Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Improved survival in medically-treated chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Effects of riociguat in patients with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary endarterectomy (PEA)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014



LATE-BREAKING ABSTRACT: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH): 2-year results from the CHEST-2 long-term extension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008